What is Brilanestrant used for?

Brilanestrant is being investigated as a potential treatment for breast cancer.

Is Brilanestrant approved for use?

No, Brilanestrant is currently in the clinical trial phase (Phase 2) and is not yet an approved medication.

What type of drug is Brilanestrant?

Brilanestrant is classified as a small molecule drug.

What is the purpose of the clinical trials for Brilanestrant?

The trials are testing the drug's effectiveness and safety specifically for breast cancer patients.

Can I take Brilanestrant for other types of cancer?

The current research specifically focuses on its use for breast cancer.

Is Brilanestrant safe?

Because it is still in clinical trials, its full safety profile and side effects are still being determined by researchers.

Brilanestrant | CAS 1365888-06-7 | BURHGPHDEVGCEZ

Loading compound...

Small molecule cancer research drug

Brilanestrant is a small molecule being studied for its potential to treat breast cancer. It is currently in the clinical development phase and is not yet an approved medication.

How it worksBrilanestrant is being researched for its ability to target specific biological pathways related to breast cancer growth.

Used for

breast cancer

Conditions

breast cancer

Class

small moleculeSmall molecule cancer research drugendocrine system

How to take

This drug is currently in clinical trials (Max Phase 2) and is not approved for general use by the FDA or other regulatory bodies.

Talk to your doctor

Questions to ask

·Is Brilanestrant part of any clinical trials I can join?
·How does Brilanestrant differ from my current breast cancer treatment?

Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-25.

How to take

Talk to your doctor

Frequently asked questions (6)